Hologic Inc (HOLX) 38.24 $HOLX
Hologic Set to Possibly Pullback After Yesterday's Rally of 1.56%
Comtex SmarTrend(R) - Mon Sep 19, 2:58PM CDT
Hologic (NASDAQ:HOLX) traded in a range yesterday that spanned from a low of $37.20 to a high of $38.28. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $37.95 on volume of 1.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HOLX: 38.24 (+0.33)
SmarTrend Watching for Potential Pullback in Shares of Hologic After 1.56% Gain
Comtex SmarTrend(R) - Mon Sep 19, 2:56PM CDT
Hologic (NASDAQ:HOLX) traded in a range yesterday that spanned from a low of $37.20 to a high of $38.28. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $37.95 on volume of 1.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HOLX: 38.24 (+0.33)
Research and Markets - Global Hepatitis B & C Diagnostics Market CAGR Growth of 6.35% by 2020 - Trends, Technologies & Opportunities Report 2016-2020 - Key Vendors: Quest Technologies, Hologic, ZEUS Scientific
PR Newswire Europe - Fri Sep 16, 8:11AM CDT
DUBLIN, September 16, 2016 /PRNewswire/ --
HOLX: 38.24 (+0.33)
Global X-Ray Equipment Market: Future Horizons and Growth Strategies - Business Assessments of Leading Suppliers
PR Newswire - Tue Sep 13, 6:00PM CDT
This report provides diagnostic imaging industry executives with strategically significant competitor information, analysis and insight crucial to the development and implementation of effective business, marketing and R&D programs. The report includes information not available from any other published source, such as sales, profit, X-Ray system placements and installed base.
HOLX: 38.24 (+0.33)
Hologic: FDA OKs Expanded Emergency Use of Zika Virus Test
Zacks Equity Research - Zacks Investment Research - Tue Sep 13, 5:48AM CDT
Hologic Inc. (HOLX) recently received emergency use authorization (EUA) from the U.S. FDA for its Aptima Zika virus assay to be used with urine samples.
GWPH: 108.29 (+2.88), QDEL: 22.91 (+0.60), NUVA: 66.89 (+0.36), HOLX: 38.24 (+0.33)
FDA Expands Emergency Use Authorization for Hologic's Aptima® Zika Virus Assay to Include Use with Urine Samples
PR Newswire - Thu Sep 08, 3:00PM CDT
Hologic, Inc. (Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has expanded the emergency use authorization (EUA) for the company's Aptima® Zika virus diagnostic assay to be used with urine samples (collected alongside patient-matched serum or plasma specimens).
HOLX: 38.24 (+0.33)
Research Report on Medical Appliances & Equipment Equities -- Abbott Laboratories, Boston Scientific, Medtronic, and Hologic
PR Newswire - Tue Aug 30, 6:35AM CDT
The Medical Appliances and Equipment industry includes companies that manufacture medical instruments such as dental and surgical appliances. Stocks in this space tend to offer below-average dividend yields when compared to the wider market. Stock-Callers.com now reviews the recent performances of the following equities: Abbott Laboratories (NYSE: ABT), Boston Scientific Corp. (NYSE: BSX), Medtronic PLC (NYSE: MDT), and Hologic Inc. (NASDAQ: HOLX). Learn more about these stocks by accessing their free research reports at:
BSX: 23.31 (-0.20), ABT: 41.58 (-0.10), MDT: 86.36 (+0.37), HOLX: 38.24 (+0.33)
FDA Advises Zika Test for All U.S. Blood: Will Hologic Gain?
Zacks Equity Research - Zacks Investment Research - Mon Aug 29, 7:37AM CDT
The recent FDA recommendation allowing Hologic???s (HOLX) Procleix assay to be one of the two tests to be used in the nationwide screening will boost its test revenue growth.
DGX: 83.10 (-0.18), IDXX: 111.83 (+1.19), HOLX: 38.24 (+0.33)
FDA expands Zika screening to all US blood centers
By MATTHEW PERRONE - AP - Fri Aug 26, 2:40PM CDT
WASHINGTON (AP) — The government told all U.S. blood banks Friday to start screening for Zika, a major expansion intended to protect the nation's blood supply from the mosquito-borne virus.
HOLX: 38.24 (+0.33)
Cigna Okays 3D Mammogram: Is Hologic Poised to Gain?
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 6:55AM CDT
Hologic's (HOLX) Genius 3D mammogram is the only clinically proven test to detect cancer 15 months earlier than traditional 2D screenings.
BABY: 43.20 (+0.24), MASI: 59.31 (-0.53), IDXX: 111.83 (+1.19), HOLX: 38.24 (+0.33)
Hologic Applauds Cigna as First National Insurer to Cover Breast Tomosynthesis for Routine Breast Cancer Screening
PR Newswire - Wed Aug 24, 3:00PM CDT
Hologic Inc. (Nasdaq: HOLX) applauds Cigna's decision to cover breast tomosynthesis for routine breast cancer screening.1 Effective immediately, this new policy provides Cigna subscribers insurance coverage for Hologic's Genius(TM) 3D MAMMOGRAPHY(TM) exam, the only mammogram clinically proven to detect cancer 15 months earlier than traditional 2D screenings.2
HOLX: 38.24 (+0.33)
Research and Markets - US Market Report for Global Endometrial Ablation 2016 Featuring Hologic, Ethicon, Boston Scientific & Cooper Surgical
PR Newswire Europe - Wed Aug 24, 10:12AM CDT
DUBLIN, August 24, 2016 /PRNewswire/ --
BSX: 23.31 (-0.20), HOLX: 38.24 (+0.33)
Global Computer Aided Detection (CAD) Market to Grow Twofold to Cross US$1 bn Mark by 2024, Reports TMR
PR Newswire Europe - Wed Aug 24, 6:31AM CDT
ALBANY, New York, August 24, 2016 /PRNewswire/ --
HOLX: 38.24 (+0.33)
Global Biopsy Devices Market Worth USD 2.46 Billion by 2021 - Analysis, Technologies & Forecasts Report 2016-2021 - Key Vendors: Hologic, Cardinal Health, Cook Medical - Research and Markets
BusinessWire - Fri Aug 12, 4:50AM CDT
Research and Markets has announced the addition of the "Global Biopsy Devices Market: Trends Analysis & Forecasts to 2021" report to their offering.
HOLX: 38.24 (+0.33)
Research and Markets - United States Fluid Management Devices Market Report 2016 Featuring Olympus, Karl Storz, Richard Wolf, Stryker & Hologic
PR Newswire Europe - Wed Aug 03, 12:10PM CDT
DUBLIN, August 3, 2016 /PRNewswire/ --
HOLX: 38.24 (+0.33)
Hologic to Webcast Presentations at Upcoming Investor Conferences
PR Newswire - Tue Aug 02, 3:01PM CDT
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at two upcoming investor conferences:
HOLX: 38.24 (+0.33)
Hologic Set to Possibly Pullback After Yesterday's Rally of 1.56%
Comtex SmarTrend(R) - Mon Sep 19, 2:58PM CDT
Hologic (NASDAQ:HOLX) traded in a range yesterday that spanned from a low of $37.20 to a high of $38.28. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $37.95 on volume of 1.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HOLX: 38.24 (+0.33)
SmarTrend Watching for Potential Pullback in Shares of Hologic After 1.56% Gain
Comtex SmarTrend(R) - Mon Sep 19, 2:56PM CDT
Hologic (NASDAQ:HOLX) traded in a range yesterday that spanned from a low of $37.20 to a high of $38.28. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $37.95 on volume of 1.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HOLX: 38.24 (+0.33)
Research and Markets - Global Hepatitis B & C Diagnostics Market CAGR Growth of 6.35% by 2020 - Trends, Technologies & Opportunities Report 2016-2020 - Key Vendors: Quest Technologies, Hologic, ZEUS Scientific
PR Newswire Europe - Fri Sep 16, 8:11AM CDT
DUBLIN, September 16, 2016 /PRNewswire/ --
HOLX: 38.24 (+0.33)
Global X-Ray Equipment Market: Future Horizons and Growth Strategies - Business Assessments of Leading Suppliers
PR Newswire - Tue Sep 13, 6:00PM CDT
This report provides diagnostic imaging industry executives with strategically significant competitor information, analysis and insight crucial to the development and implementation of effective business, marketing and R&D programs. The report includes information not available from any other published source, such as sales, profit, X-Ray system placements and installed base.
HOLX: 38.24 (+0.33)
Hologic: FDA OKs Expanded Emergency Use of Zika Virus Test
Zacks Equity Research - Zacks Investment Research - Tue Sep 13, 5:48AM CDT
Hologic Inc. (HOLX) recently received emergency use authorization (EUA) from the U.S. FDA for its Aptima Zika virus assay to be used with urine samples.
GWPH: 108.29 (+2.88), QDEL: 22.91 (+0.60), NUVA: 66.89 (+0.36), HOLX: 38.24 (+0.33)
FDA Expands Emergency Use Authorization for Hologic's Aptima® Zika Virus Assay to Include Use with Urine Samples
PR Newswire - Thu Sep 08, 3:00PM CDT
Hologic, Inc. (Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has expanded the emergency use authorization (EUA) for the company's Aptima® Zika virus diagnostic assay to be used with urine samples (collected alongside patient-matched serum or plasma specimens).
HOLX: 38.24 (+0.33)
Research Report on Medical Appliances & Equipment Equities -- Abbott Laboratories, Boston Scientific, Medtronic, and Hologic
PR Newswire - Tue Aug 30, 6:35AM CDT
The Medical Appliances and Equipment industry includes companies that manufacture medical instruments such as dental and surgical appliances. Stocks in this space tend to offer below-average dividend yields when compared to the wider market. Stock-Callers.com now reviews the recent performances of the following equities: Abbott Laboratories (NYSE: ABT), Boston Scientific Corp. (NYSE: BSX), Medtronic PLC (NYSE: MDT), and Hologic Inc. (NASDAQ: HOLX). Learn more about these stocks by accessing their free research reports at:
BSX: 23.31 (-0.20), ABT: 41.58 (-0.10), MDT: 86.36 (+0.37), HOLX: 38.24 (+0.33)
FDA Advises Zika Test for All U.S. Blood: Will Hologic Gain?
Zacks Equity Research - Zacks Investment Research - Mon Aug 29, 7:37AM CDT
The recent FDA recommendation allowing Hologic???s (HOLX) Procleix assay to be one of the two tests to be used in the nationwide screening will boost its test revenue growth.
DGX: 83.10 (-0.18), IDXX: 111.83 (+1.19), HOLX: 38.24 (+0.33)
FDA expands Zika screening to all US blood centers
By MATTHEW PERRONE - AP - Fri Aug 26, 2:40PM CDT
WASHINGTON (AP) — The government told all U.S. blood banks Friday to start screening for Zika, a major expansion intended to protect the nation's blood supply from the mosquito-borne virus.
HOLX: 38.24 (+0.33)
Cigna Okays 3D Mammogram: Is Hologic Poised to Gain?
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 6:55AM CDT
Hologic's (HOLX) Genius 3D mammogram is the only clinically proven test to detect cancer 15 months earlier than traditional 2D screenings.
BABY: 43.20 (+0.24), MASI: 59.31 (-0.53), IDXX: 111.83 (+1.19), HOLX: 38.24 (+0.33)
Hologic Applauds Cigna as First National Insurer to Cover Breast Tomosynthesis for Routine Breast Cancer Screening
PR Newswire - Wed Aug 24, 3:00PM CDT
Hologic Inc. (Nasdaq: HOLX) applauds Cigna's decision to cover breast tomosynthesis for routine breast cancer screening.1 Effective immediately, this new policy provides Cigna subscribers insurance coverage for Hologic's Genius(TM) 3D MAMMOGRAPHY(TM) exam, the only mammogram clinically proven to detect cancer 15 months earlier than traditional 2D screenings.2
HOLX: 38.24 (+0.33)
Research and Markets - US Market Report for Global Endometrial Ablation 2016 Featuring Hologic, Ethicon, Boston Scientific & Cooper Surgical
PR Newswire Europe - Wed Aug 24, 10:12AM CDT
DUBLIN, August 24, 2016 /PRNewswire/ --
BSX: 23.31 (-0.20), HOLX: 38.24 (+0.33)
Global Computer Aided Detection (CAD) Market to Grow Twofold to Cross US$1 bn Mark by 2024, Reports TMR
PR Newswire Europe - Wed Aug 24, 6:31AM CDT
ALBANY, New York, August 24, 2016 /PRNewswire/ --
HOLX: 38.24 (+0.33)
Global Biopsy Devices Market Worth USD 2.46 Billion by 2021 - Analysis, Technologies & Forecasts Report 2016-2021 - Key Vendors: Hologic, Cardinal Health, Cook Medical - Research and Markets
BusinessWire - Fri Aug 12, 4:50AM CDT
Research and Markets has announced the addition of the "Global Biopsy Devices Market: Trends Analysis & Forecasts to 2021" report to their offering.
HOLX: 38.24 (+0.33)
Research and Markets - United States Fluid Management Devices Market Report 2016 Featuring Olympus, Karl Storz, Richard Wolf, Stryker & Hologic
PR Newswire Europe - Wed Aug 03, 12:10PM CDT
DUBLIN, August 3, 2016 /PRNewswire/ --
HOLX: 38.24 (+0.33)
Hologic to Webcast Presentations at Upcoming Investor Conferences
PR Newswire - Tue Aug 02, 3:01PM CDT
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at two upcoming investor conferences:
HOLX: 38.24 (+0.33)
